Overview

The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to analyze the effects of the addition of sulfonylurea (gliclazide MR) or ,alternatively, basal insulin (insulin detemir) to life-style modification and metformin treatment as a second step treatment in type 2 diabetes mellitus on endothelial cell functions. The second goal is to identify the effects of these treatment alternatives on body-mass index, the changes in body fat mass, insulin resistance and on the insulin secretion capacity of beta cells. The third aim of this study is to determine the success rates of these treatment alternatives on glycemic control at 6 months follow-up.
Phase:
N/A
Details
Lead Sponsor:
Ankara University
Collaborators:
Hacettepe University
The Scientific and Technological Research Council of Turkey
Tubitak
Treatments:
Gliclazide
Insulin
Insulin Detemir
Insulin, Globin Zinc